CHUM-Notre-Dame Hospital

Montreal, Quebec H2L 4M1

0 studies enrolling now · 7 studies all time

What they study most

Coronary Artery Disease, Follicular Lymphoma, HER2+ Metastatic Breast Cancer (MBC), Huntington's Disease, Prostate Cancer, Refractory Multiple Myeloma, Relapsed Multiple Myeloma

Studies at this site

• Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma — Completed
• A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma — Completed
• A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting — Completed
• Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021 — Stopped early
• Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease — Completed
• TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions — Completed
• ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere — Status unconfirmed